Quick View
| Metric | Current Period | Same Period Last Year | YoY |
|---|---|---|---|
| Revenue | ¥269.4B | ¥273.6B | −1.5% |
| Operating Income | ¥25.9B | ¥19.2B | +35.0% |
| Ordinary Income | ¥28.6B | ¥22.0B | +29.9% |
| Net Income | ¥22.5B | ¥14.6B | +54.0% |
| ROE | 5.7% | 3.9% | - |
Executive Summary
Cumulative results for the first three quarters recorded a substantial increase in profit despite lower revenue, with improved profitability being the central feature of performance. Revenue declined slightly to ¥269.4B (down 1.5% YoY), while Operating Income rose significantly to ¥25.9B (up 35.0%), Ordinary Income to ¥28.6B (up 29.9%), and quarterly Net Income attributable to owners of the parent to ¥22.5B (up 54.0%). The Operating Income margin improved to 9.6% from the previous year, primarily due to improved profitability centered on the Chemicals segment. The fact that the increase in Net Income exceeded that of Operating Income was attributable to the recognition of extraordinary income, including a gain on the sale of investment securities of ¥6.6B.
Factors Affecting Performance
【Revenue】Revenue declined 1.5% YoY to ¥269.4B. While the core Chemicals segment decreased to ¥153.4B (down 3.5% YoY), Metal Processing at ¥55.8B and Engineering Services at ¥27.5B recorded revenue growth, while Bottling declined slightly to ¥33.9B. The primary reason for the revenue decline was a decrease in sales volume in Chemicals, partially offset by higher revenue in the other segments.
【Profit and Loss】Operating Income was ¥25.9B (up 35.0% YoY), Ordinary Income was ¥28.6B (up 29.9%), and Net Income was ¥22.5B (up 54.0%). The improvement in the Operating Income margin to 9.6% was largely attributable to the effects of product mix improvement and profitability normalization, with the Chemicals margin rising from 5.4% to 9.1% and the Engineering Services margin increasing from 16.6% to 23.3%. The primary reason Ordinary Income exceeded Operating Income was ¥3.4B in non-operating income, including ¥2.3B in dividend income received. Net Income grew more than Ordinary Income because extraordinary income of ¥6.7B, including a ¥6.6B gain on the sale of investment securities, contributed to results. At the same time, extraordinary losses of ¥1.9B were recorded, including a ¥1.2B impairment loss related to silicon wafers. In conclusion, the Company achieved lower revenue and higher profit.
Segment Analysis
Chemicals is the core business, generating segment profit of ¥13.9B and accounting for 50.7% of the total. Its margin improved from 5.4% to 9.1% despite lower revenue, making it the central driver of consolidated profit growth. Engineering Services generated revenue of ¥27.5B, profit of ¥6.4B, and the highest margin at 23.3%, recording higher revenue and profit alongside an expansion in internal sales. Metal Processing generated revenue of ¥55.8B, profit of ¥5.0B, and an improved margin of 9.0%, resulting in higher revenue and profit. Bottling was the only segment to record both lower revenue and lower profit, with revenue of ¥33.9B (down 2.0% YoY) and profit of ¥2.1B (down 9.9% YoY), partially offsetting profit growth in the other segments.
Key Financial Metrics
【Profitability】The Operating Income margin of 9.6% and Net Income margin of 8.4% both improved from the same period of the previous year, indicating that profit growth was driven not by expanded sales volume but by improved margins. ROE was 5.7%, comprising the product of a Net Income margin of 8.4%, total asset turnover of 0.455x, and financial leverage of 1.51x. 【Cash Quality】Net Income includes a pretax net amount of extraordinary income and losses of ¥4.7B, including a ¥6.6B gain on the sale of investment securities. This represents 14.2% of pretax income of ¥33.3B and therefore needs to be evaluated separately from recurring earnings power. 【Investment Efficiency】Total asset turnover of 0.455x is low relative to the asset base, which includes ¥109.6B in investment securities and ¥226.2B in property, plant and equipment, and is the primary factor suppressing ROE. 【Financial Soundness】The financial base is conservative, with an Equity Ratio of 66.3%, interest-bearing debt of ¥30.6B, and interest coverage of approximately 70x. However, most interest-bearing debt consists of short-term borrowings, and the concentration in short-term liabilities requires attention from a funding perspective.
Cash Flow Analysis
Because the statement of cash flows has not been disclosed, cash trends are analyzed based on changes in the balance sheet. Cash and deposits declined to ¥45.2B from ¥49.5B in the same period of the previous year, while investment securities increased to ¥109.6B from ¥86.3B in the previous year, suggesting that a portion of excess funds was allocated to securities investments. Property, plant and equipment also increased to ¥226.2B, with continued capital investment contributing to the growth in assets. Trade receivables of ¥101.3B and inventories of ¥38.5B both increased from the previous year, potentially indicating that the buildup of working capital was one factor contributing to funds being tied up. The current ratio of 163.0% and quick ratio of 136.0% are at favorable levels, providing sufficient room for short-term liquidity management.
Quality of Earnings
Net Income of ¥22.5B includes extraordinary income of ¥6.7B, including a ¥6.6B gain on the sale of investment securities. After deducting extraordinary losses of ¥1.9B, including a ¥1.2B impairment loss, the pretax net amount of ¥4.7B accounts for 14.2% of pretax income of ¥33.3B. Accordingly, the 54.0% growth in Net Income includes a substantial contribution from temporary factors compared with the 35.0% growth in Operating Income, and the degree of improvement in recurring earnings power can be evaluated more appropriately through the improvement in the Operating Income margin (approximately 2.6 percentage points YoY). Non-operating income was ¥3.4B, primarily consisting of ¥2.3B in dividend income received. As this represents stable income from investment holdings, it can be viewed as part of the recurring earnings base. Comprehensive Income was ¥39.5B, substantially exceeding Net Income of ¥22.5B. The difference was attributable to ¥17.1B in valuation differences on securities, with the mark-to-market valuation of held shares boosting Comprehensive Income.
Earnings Forecast and Guidance
Progress against the full-year Company forecast was 70.9% for Revenue, 73.9% for Operating Income, 77.3% for Ordinary Income, and 79.1% for Net Income, all around the standard progress level of approximately 75%. To achieve the full-year plan, fourth-quarter Revenue of ¥110.6B (approximately 15.5% higher than the same period of the previous year) and Operating Income of ¥9.1B will be required. The required Operating Income margin is approximately 8.3%, below the 9.6% recorded for the cumulative first three quarters. The Company’s plan therefore assumes an acceleration in revenue and a partial reversal of the high margins that became evident during the cumulative period.
Shareholder Returns
The Q2 dividend was ¥0 per share, while the full-year annual dividend forecast is ¥38.0 per share. Based on forecast EPS of ¥125.25, the forecast Payout Ratio is 30.3%, below the generally accepted sustainability benchmark of 60%, leaving sufficient capacity for earnings-based returns. Relative to cumulative Q3 EPS of ¥98.33, the annual dividend forecast corresponds to 38.6%. Retained earnings of ¥306.6B and Net Assets of ¥392.6B provide a substantial base for dividend funding. However, current-period Net Income includes a temporary uplift primarily from gains on the sale of investment securities, meaning dividend sustainability depends on the maintenance of recurring earnings power.
Risk Factors
-
Declining asset profitability in the Chemicals segment: An impairment loss of ¥1.2B was recorded on fixed assets in the silicon wafer field. If the deterioration in asset profitability in a core business continues, the risk of additional impairment remains.
-
Extension of the trade receivables collection period: DSO is approximately 103 days, above the efficient benchmark for the manufacturing industry. A prolonged collection period for trade receivables of ¥101.3B could tie up working capital and increase sensitivity to bad debt risk.
-
Dependence on short-term borrowings: Of interest-bearing debt of ¥30.6B, short-term borrowings account for ¥30.0B, representing approximately 98%. While cash and deposits of ¥45.2B and a current ratio of 163.0% provide a buffer, refinancing conditions and changes in funding costs require ongoing monitoring.
Industry Benchmark (For Reference; Compiled by the Company)
Industry Benchmark (manufacturing)
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Income Margin | 9.6% | 8.6% (4.3%–12.7%) | +1.0pt |
| Net Income Margin | 8.4% | 6.4% (2.8%–10.3%) | +1.9pt |
Both the Operating Income margin and Net Income margin are above the industry median.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | −1.5% | 3.3% (-2.1%–8.9%) | −4.8pt |
The Revenue growth rate is below the industry median, with improved profitability offsetting the decline in revenue.
※Source: Compiled by the Company
Key Takeaways from the Earnings Results
-
While Revenue declined 1.5% YoY, Operating Income increased 35.0% and the Operating Income margin improved. A notable feature is that profit growth was driven not by expanded sales volume, but by margin improvement through product mix improvement and profitability normalization, primarily in Chemicals.
-
The 54.0% growth in Net Income benefited from extraordinary income and losses, including a ¥6.6B gain on the sale of investment securities. Consequently, it includes temporary factors compared with the improvement in Operating Income and Ordinary Income. The trend in the Operating Income margin is a more appropriate indicator for evaluating recurring earnings power.
-
While the financial base is conservative, with an Equity Ratio of 66.3% and interest coverage of approximately 70x, DSO of approximately 103 days and the concentration in short-term borrowings are matters requiring attention in terms of working capital efficiency and the funding structure.
Theoretical Stock Price (Reference Value)
| Scenario | Theoretical Stock Price |
|---|---|
| bear (bearish) | ¥1,609 |
| base (base case) | ¥1,642 |
| bull (bullish) | ¥1,668 |
| Calculation Assumption | Value |
|---|---|
| Book Value per Share (BPS) | ¥1,741 |
| Adjusted Forecast EPS | ¥134.6 |
| Cost of Equity r | 9.77% (10-year JGB 2.77% + Equity Risk Premium 6.00% + Size Premium 1.00%) |
| Residual Income Persistence Factor ω / Explicit Forecast Period | 0.62 / 5 years |
| Assumed Payout Ratio | 30.3% |
| Forecast EPS Confidence Adjustment | ×1.075 (based on the industry’s historical guidance achievement rate) |
| Implied PBR / PER | 0.94x / 12.2x |
Sensitivity: ¥1,596–¥1,689 at Cost of Equity ±1%, and ¥1,638–¥1,644 at ω±0.1.
Notes:
- Because forecast ROE is below the Cost of Equity, the theoretical value is below Book Value per Share.
- Net Assets at the end of the quarter are used (there is a timing gap relative to the full-year forecast).
(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / This is a mechanically calculated value based solely on publicly disclosed data and is not a forecast of the market stock price, a recommendation of any specific investment action, or a prediction or guarantee of the future stock price.)
This report is an earnings analysis document automatically generated by AI through analysis of XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting professionals as necessary.
---End of Report---
AI Financial Analysis
Executive Summary
Carlit delivered a strong FY2026 Q3 cumulative earnings result, with operating profit expanding sharply despite a modest revenue decline. Revenue was ¥26.95bn, down 1.5% year on year. Operating income increased 35.0% to ¥2.59bn. The operating margin improved by 260bp to 9.6%, from 7.0% in the prior-year period. Gross profit rose 5.1% to ¥7.06bn despite lower sales, lifting the gross margin by 160bp to 26.2%. SG&A expenses declined 6.8% to ¥4.47bn, versus the revenue decline of 1.5%, providing substantial operating leverage. Ordinary income rose 29.9% to ¥2.86bn. Net income attributable to owners increased 54.0% to ¥2.25bn, outpacing operating-income growth. However, net income benefited from a ¥0.66bn gain on sales of investment securities. Net extraordinary gains were ¥0.47bn after a ¥0.12bn impairment loss and ¥0.07bn fixed-asset disposal loss, making bottom-line growth less recurring than the operating result. The impairment was related to fixed assets in the silicon-wafer business within the Chemicals segment, indicating that this activity remains under earnings pressure. Comprehensive income nearly doubled to ¥3.95bn, supported by a ¥1.71bn positive valuation difference on securities. The Chemicals segment remained the core business by operating-income contribution, generating ¥1.39bn, or approximately 51% of aggregate segment profit. Engineering Services was the fastest-growing segment on a profit basis, while Bottling was the only segment to report lower profit. Financial leverage remains conservative, with interest-bearing debt of ¥3.06bn and debt/capital of 7.2%. Liquidity is sound, although the debt structure is heavily concentrated in short-term borrowings and receivable collection remains slow. Full-year guidance appears broadly achievable, with nine-month operating-income progress of 73.9% against the full-year forecast. The principal forward implication is that management must convert the improved gross-margin and cost discipline into recurring profit while managing silicon-wafer impairment risk, receivable collection, and short-term debt refinancing.
Profitability Analysis
Annualized DuPont ROE is 7.7%, decomposed into an 8.4% net profit margin, 0.606x asset turnover, and 1.51x financial leverage. The largest positive earnings driver was margin expansion rather than revenue growth or leverage. The operating margin rose to 9.6%, a 260bp improvement year on year, reflecting a 160bp increase in gross margin to 26.2% and a 6.8% reduction in SG&A expenses. This is favorable operating leverage: gross profit increased by ¥0.34bn while SG&A fell by ¥0.33bn, producing a ¥0.67bn increase in operating income. Revenue contraction limits the extent to which the result can be characterized as demand-led growth, but the gross-margin improvement suggests better pricing, product mix, or manufacturing cost absorption. The annualized 0.606x asset-turnover ratio remains moderate, consistent with the capital-intensive manufacturing asset base, including PPE equal to 38.2% of total assets. Financial leverage is modest and is not the source of the profit improvement. Interest coverage is very strong at 69.95x, and the interest burden factor of 1.288x reflects non-operating income exceeding interest expense rather than financing stress. Dividend income of ¥0.23bn represented the majority of non-operating income and supported ordinary income. The tax burden factor was 0.676, corresponding to a 32.4% effective tax rate. The annualized 7.7% ROE is below the 8% threshold generally associated with an adequate return profile, despite the improved margin. Profitability therefore improved materially, but a sustained recovery in sales and more efficient use of the expanded asset base would be needed to lift returns further.
Growth Assessment
Revenue fell 1.5% year on year to ¥26.95bn, but segment trends were mixed. Chemicals revenue declined 3.5% to ¥15.34bn, yet segment profit rose 60.8% to ¥1.39bn; its segment margin improved to approximately 9.1% from 5.4%. Bottling revenue declined 2.0% to ¥3.39bn and segment profit fell 9.9% to ¥0.21bn, reducing its margin to approximately 6.2% from 6.7%. Metal Processing revenue grew 2.5% to ¥5.47bn and segment profit increased 30.3% to ¥0.50bn, lifting its margin to approximately 9.2%. Engineering Services revenue rose 3.2% to ¥2.75bn and segment profit increased 45.0% to ¥0.64bn; its approximately 23.3% margin was the highest among reported segments. Chemicals remains the core business by both sales and operating-income contribution, but the silicon-wafer impairment indicates that recovery is not uniform within the segment. Internal sales at Engineering Services increased materially, which may reflect stronger group project activity but does not directly translate into external revenue growth. Full-year revenue guidance is ¥38.00bn, implying nine-month progress of 70.9%, 4.1 percentage points below the standard 75% Q3 run rate. Operating-income progress is 73.9% against the ¥3.50bn full-year forecast, only 1.1 percentage points below the standard pace. Ordinary-income progress is 77.3% against guidance, while net-income progress is 79.1% against the ¥2.85bn forecast. The company needs only ¥0.91bn of operating income and ¥0.60bn of net income in Q4 to meet its forecasts. Guidance therefore appears operationally attainable, although the low revenue progress rate means Q4 sales execution remains important.
Financial Health
The balance sheet is sound, with total equity of ¥39.26bn representing a 66.3% capital adequacy ratio. The current ratio is 163.0% and the quick ratio is 136.0%, both indicating adequate near-term liquidity. Working capital totals ¥9.00bn. Interest-bearing debt is limited at ¥3.06bn, equivalent to debt/capital of 7.2% and approximately 0.08x total equity. Interest coverage of 69.95x provides a substantial buffer against financing costs. Cash and deposits of ¥4.53bn cover short-term loans of ¥3.00bn by 1.51x. However, 98.1% of interest-bearing debt is short-term, creating a refinancing and maturity-management risk even though liquidity currently covers the borrowings. Current liabilities increased 43.8% year on year to ¥14.28bn, led by higher trade payables and other current liabilities, making working-capital discipline important. Trade receivables increased 5.0% to ¥10.13bn and represent 17.1% of total assets. The reported annualized DSO of 103 days is elevated for a manufacturing company and indicates slow cash collection or a customer mix with extended payment terms. Investment securities increased 26.9% to ¥10.96bn and now account for 18.5% of total assets; this adds market-value sensitivity to equity through securities valuation gains and losses. Positive securities valuation adjustments contributed ¥1.71bn to OCI during the period. Long-term loans declined 74.9% to ¥0.06bn, reducing structural long-term leverage. There are ¥0.34bn of net defined-benefit liabilities and ¥0.38bn of bonus provisions, neither of which appears material relative to total liabilities.
Notable B/S Changes
Treasury stock: increased in absolute value by ¥0.28bn to negative ¥0.61bn (+82.9%) - indicates additional share repurchases or treasury-share acquisition, modestly reducing equity. Long-term loans: decreased by ¥0.18bn to ¥0.06bn (-74.9%) - lowers long-term leverage but further concentrates the borrowing structure in short-term debt. Intangible assets: increased by ¥0.27bn to ¥0.75bn (+56.5%) - still only 1.3% of total assets, so amortization and impairment exposure remains limited. Investment securities: increased by ¥2.33bn to ¥10.96bn (+26.9%) - now 18.5% of total assets and increases sensitivity of equity and comprehensive income to market valuations. Construction in progress: increased by ¥1.37bn to ¥2.85bn (+92.0%) - signals a sizable manufacturing investment pipeline; completion timing and return on invested capital should be monitored. Current liabilities: increased by ¥4.35bn to ¥14.28bn (+43.8%) - raises working-capital funding needs despite the currently healthy liquidity ratios.
Cash Flow Quality
Operating cash flow, investing cash flow, free cash flow, and capital expenditure data are not reported in the available financial data, so cash-conversion and free-cash-flow coverage metrics cannot be assessed. The earnings-quality assessment can nevertheless be made from the income statement and working-capital balance. Net income of ¥2.25bn exceeded the more recurring operating-income base after benefiting from a ¥0.66bn gain on sales of investment securities. Net extraordinary gains were ¥0.47bn before tax, equal to approximately 21% of reported net income, which makes reported bottom-line growth less repeatable than operating-profit growth. The silicon-wafer impairment loss of ¥0.12bn partially offsets the securities gain but also signals lower expected recoverability of assets in that business. Elevated annualized receivable days of 103 are a working-capital risk and may delay conversion of earnings into cash. Receivables of ¥10.13bn exceeded cash and deposits of ¥4.53bn, reinforcing the importance of collection performance. Inventories were ¥3.86bn, including ¥1.98bn of raw materials, ¥0.59bn of work in process, and ¥3.86bn of finished goods as separately reported. Construction in progress rose to ¥2.85bn from ¥1.48bn, indicating an active investment pipeline that will require monitoring for project completion and returns. The absence of reported cash-flow figures prevents confirmation that internally generated cash funds this investment and shareholder distributions.
Dividend Sustainability
The full-year dividend forecast is ¥38.00 per share. Against forecast EPS of ¥125.25, the implied dividend payout ratio is approximately 30.3%, which is conservative and below the 60% sustainability benchmark. The forecast dividend requires a relatively modest portion of forecast net income. Nine-month EPS was ¥98.33, equivalent to 78.5% of full-year forecast EPS, broadly consistent with the 79.1% net-income progress rate. The reported Q2 DPS is ¥0, so the indicated annual shareholder distribution appears to be concentrated in the year-end dividend. Retained earnings were ¥30.66bn, providing substantial accounting capacity for dividends. Balance-sheet leverage is low, and cash exceeds short-term loans, which supports financial flexibility. However, free-cash-flow coverage cannot be verified because operating cash flow and capital expenditure are not reported. Dividend sustainability is therefore supported by forecast earnings, retained earnings, and low leverage, while actual cash generation and investment outlays remain the key confirmation points.
Risk Assessment
Business risks include Silicon-wafer operations in the Chemicals segment incurred a ¥0.12bn impairment loss, indicating demand, utilization, pricing, or asset-return risk in that activity., Revenue declined 1.5% overall, with Chemicals and Bottling both reporting lower external sales; sustained profit expansion depends on margins remaining resilient despite softer volumes., The chemical and manufacturing businesses face exposure to raw-material, energy-cost, environmental-regulatory, product-quality, and supply-chain disruptions., Bottling segment profit declined 9.9% year on year, indicating weaker earnings momentum than the other operating segments., Investment securities equal 18.5% of total assets, exposing comprehensive income and equity to market-price volatility..
Financial risks include Short-term debt represents 98.1% of interest-bearing debt. This is a refinancing-risk alert because funding is concentrated in borrowings requiring near-term rollover, although cash/short-term debt of 1.51x mitigates immediate pressure., Annualized DSO of 103 days is a material receivable-collection alert, well above the 60-day warning threshold. Slow collection can depress operating cash conversion and raise credit-loss exposure., Current liabilities increased 43.8% year on year, which increases the importance of preserving liquidity and managing payables, taxes, and other working-capital obligations., Net income includes a ¥0.66bn gain on sale of investment securities, creating a risk that reported earnings growth overstates recurring profit growth..
Key concerns include The primary risk is the combination of weak top-line momentum and reliance on margin improvement to deliver earnings growth., The second priority is working-capital quality: elevated receivable days should be monitored against actual operating cash generation., The third priority is the silicon-wafer impairment, which could foreshadow further restructuring charges or indicate weaker returns on recently deployed manufacturing assets., Short-term debt concentration is not currently a solvency problem because liquidity and leverage are strong, but it remains a maturity-management consideration., Securities gains and valuation gains supported total and comprehensive income; these items are more volatile than operating earnings..
Investment Implications
Key takeaways include Operating profit increased 35.0% despite a 1.5% revenue decline, driven by gross-margin expansion and lower SG&A., The operating margin improved 260bp to 9.6%, placing profitability in a solid range for the stated benchmarks., Chemicals is the core earnings contributor, while Engineering Services delivers the highest segment margin., Net income growth of 54.0% was partly supported by a ¥0.66bn securities-sale gain and should not be viewed as entirely recurring., The balance sheet is conservatively financed, but receivable days and short-term debt concentration require monitoring., Full-year operating and net-income guidance appears within reach based on nine-month progress..
Metrics to watch include Chemicals segment sales, margin, and any additional silicon-wafer impairment or restructuring charges, Annualized DSO and the subsequent movement in trade receivables, Q4 revenue needed to close the gap between 70.9% nine-month sales progress and the full-year forecast, Operating cash flow, capital expenditure, and free-cash-flow coverage of dividends, Short-term borrowing rollover terms and cash/short-term debt coverage, Investment-security valuation movements and recurring versus realized securities gains.
Regarding relative positioning, Carlit combines a good 9.6% operating margin, strong interest coverage, healthy current and quick ratios, and low debt/capital. Its annualized ROE of 7.7% remains modest relative to higher-return industrial peers, reflecting moderate asset turnover and a sizeable capital base. Compared with a typical leveraged cyclical manufacturer, balance-sheet risk is low; compared with highly efficient manufacturers, elevated receivable days and the impairment in the silicon-wafer activity are weaker features.